PCRX logo

Pacira BioSciences (PCRX) Depreciation And Amortization

Annual D&A

$75.57 M
-$15.93 M-17.41%

December 31, 2023

Summary

Performance

1-Year Change

-17.41%

3-Year Change

+279.62%

5-Year Change

+474.05%

15-Year Change

+446.33%

PCRX Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

88.06%
PCRX annual depreciation & amortization is higher than 88.06% of companies in Healthcare sector

High & Low

All-time High

$91.50 M
PCRX annual depreciation & amortization is currently -17.41% below its historical high of $91.50 million

3-Year Low

$28.55 M
PCRX annual depreciation & amortization is currently +164.73% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
PCRX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
PCRX next annual earnings announcement is scheduled for Feb 28, 2025

Related metrics

Annual Total Expenses

$587.65 M
PCRX annual total expenses is $587.65 million

Annual Operating Expenses

$402.99 M
PCRX annual total operating expenses is $402.99 million

Annual Cost Of Goods Sold

$184.67 M
PCRX annual cost of goods sold is $184.67 million

Annual Interest Expense

$17.31 M
PCRX annual interest expense is $17.31 million

Quarterly D&A

$20.25 M
+$1.39 M+7.37%

September 30, 2024

Summary

Performance

3-Month Change

+7.37%

1-Year Change

+9.87%

3-Year Change

+1.1%

5-Year Change

+1.1%

PCRX Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

88.24%
PCRX quarterly depreciation & amortization is higher than 88.24% of companies in Healthcare sector

High & Low

All-time High

$30.41 M
PCRX quarterly depreciation & amortization is currently -33.39% below its historical high of $30.41 million

3-Year Low

$13.07 M
PCRX quarterly depreciation & amortization is currently +54.96% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PCRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
PCRX next earnings announcement is scheduled for Feb 28, 2025

Related metrics

Quarterly Total Expenses

$146.62 M
PCRX quarterly total expenses is $146.62 million

Quarterly Operating Expenses

$107.76 M
PCRX quarterly total operating expenses is $107.76 million

Quarterly Cost Of Goods Sold

$38.86 M
PCRX quarterly cost of goods sold is $38.86 million

Quarterly Interest Expense

$3.85 M
PCRX quarterly interest expense is $3.85 million

TTM D&A

$76.03 M
+$1.82 M+2.45%

September 30, 2024

Summary

Performance

3-Month Change

+2.45%

1-Year Change

-13.11%

3-Year Change

+73.86%

5-Year Change

+73.86%

PCRX TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

87.87%
PCRX TTM depreciation & amortization is higher than 87.87% of companies in Healthcare sector

High & Low

All-time High

$91.50 M
PCRX TTM depreciation & amortization is currently -16.91% below its historical high of $91.50 million

3-Year Low

$28.55 M
PCRX TTM depreciation & amortization is currently +166.31% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PCRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
PCRX next earnings announcement is scheduled for Feb 28, 2025

Related metrics

Annual Total Expenses

$587.65 M
PCRX annual total expenses is $587.65 million

Annual Operating Expenses

$402.99 M
PCRX annual total operating expenses is $402.99 million

TTM Cost Of Goods Sold

$178.23 M
PCRX TTM cost of goods sold is $178.23 million

TTM Interest Expense

$12.31 M
PCRX TTM interest expense is $12.31 million

PCRX Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-17.4%+9.9%-13.1%
3 y3 years+279.6%+1.1%+73.9%
5 y5 years+474.1%+1.1%+73.9%

PCRX Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-17.4%+164.7%-33.4%+55.0%-16.9%+166.3%
5 y5-year-17.4%+286.1%-33.4%+320.1%-16.9%+288.4%
alltimeall time-17.4%+1872.7%-33.4%+2101.3%-16.9%-100.0%

Pacira BioSciences Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sep 2024
-
$20.25 M(+7.4%)
$76.03 M(+2.5%)
Jun 2024
-
$18.86 M(+2.4%)
$74.21 M(-0.3%)
Mar 2024
-
$18.43 M(-0.3%)
$74.40 M(-1.6%)
Dec 2023
$75.57 M(-17.4%)
$18.48 M(+0.3%)
$75.57 M(-13.6%)
Sep 2023
-
$18.43 M(-3.3%)
$87.50 M(-2.0%)
Jun 2023
-
$19.05 M(-2.8%)
$89.26 M(-2.0%)
Mar 2023
-
$19.60 M(-35.5%)
$91.07 M(-0.5%)
Dec 2022
$91.50 M(+220.5%)
$30.41 M(+50.5%)
$91.50 M(+23.4%)
Sep 2022
-
$20.20 M(-3.2%)
$74.17 M(+24.2%)
Jun 2022
-
$20.86 M(+4.1%)
$59.70 M(+36.5%)
Mar 2022
-
$20.03 M(+53.3%)
$43.73 M(+53.2%)
Dec 2021
$28.55 M(+43.4%)
$13.07 M(+128.1%)
$28.55 M(+39.0%)
Sep 2021
-
$5.73 M(+17.0%)
$20.54 M(+3.5%)
Jun 2021
-
$4.90 M(+0.9%)
$19.85 M(-0.5%)
Mar 2021
-
$4.85 M(-4.1%)
$19.94 M(+0.2%)
Dec 2020
$19.91 M(+1.7%)
$5.06 M(+0.5%)
$19.91 M(-0.1%)
Sep 2020
-
$5.04 M(+1.0%)
$19.94 M(-2.8%)
Jun 2020
-
$4.99 M(+3.5%)
$20.50 M(-1.4%)
Mar 2020
-
$4.82 M(-5.3%)
$20.80 M(+6.2%)
Dec 2019
$19.58 M(+48.7%)
$5.09 M(-9.2%)
$19.58 M(+5.6%)
Sep 2019
-
$5.61 M(+6.1%)
$18.54 M(+12.8%)
Jun 2019
-
$5.28 M(+46.7%)
$16.44 M(+17.4%)
Mar 2019
-
$3.60 M(-11.1%)
$14.00 M(+6.4%)
Dec 2018
$13.16 M(-4.8%)
$4.05 M(+15.6%)
$13.16 M(+3.1%)
Sep 2018
-
$3.50 M(+23.0%)
$12.77 M(+1.1%)
Jun 2018
-
$2.85 M(+3.1%)
$12.63 M(-6.4%)
Mar 2018
-
$2.76 M(-24.5%)
$13.49 M(-2.5%)
Dec 2017
$13.83 M
$3.66 M(+8.9%)
$13.83 M(+3.0%)
Sep 2017
-
$3.36 M(-9.4%)
$13.43 M(+0.6%)
Jun 2017
-
$3.71 M(+19.5%)
$13.35 M(+3.8%)
DateAnnualQuarterlyTTM
Mar 2017
-
$3.10 M(-4.8%)
$12.86 M(-0.5%)
Dec 2016
$12.92 M(+12.6%)
$3.26 M(-0.5%)
$12.92 M(+1.1%)
Sep 2016
-
$3.28 M(+1.9%)
$12.78 M(+3.6%)
Jun 2016
-
$3.22 M(+1.6%)
$12.33 M(+3.6%)
Mar 2016
-
$3.17 M(+1.5%)
$11.90 M(+3.7%)
Dec 2015
$11.47 M(+14.3%)
$3.12 M(+10.2%)
$11.47 M(+3.7%)
Sep 2015
-
$2.83 M(+1.7%)
$11.06 M(+4.1%)
Jun 2015
-
$2.78 M(+1.5%)
$10.63 M(+4.4%)
Mar 2015
-
$2.74 M(+1.3%)
$10.18 M(+1.4%)
Dec 2014
$10.04 M(+74.6%)
$2.71 M(+13.2%)
$10.04 M(+11.2%)
Sep 2014
-
$2.39 M(+2.5%)
$9.03 M(+13.3%)
Jun 2014
-
$2.33 M(-10.4%)
$7.97 M(+15.1%)
Mar 2014
-
$2.60 M(+53.1%)
$6.92 M(+20.4%)
Dec 2013
$5.75 M(+1.8%)
$1.70 M(+27.8%)
$5.75 M(+4.6%)
Sep 2013
-
$1.33 M(+3.4%)
$5.49 M(-1.6%)
Jun 2013
-
$1.29 M(-10.1%)
$5.58 M(-2.1%)
Mar 2013
-
$1.43 M(-1.0%)
$5.70 M(+0.9%)
Dec 2012
$5.65 M(+30.9%)
$1.45 M(+2.0%)
$5.65 M(+3.0%)
Sep 2012
-
$1.42 M(+0.9%)
$5.49 M(+7.6%)
Jun 2012
-
$1.41 M(+1.8%)
$5.10 M(-10.5%)
Mar 2012
-
$1.38 M(+7.5%)
$5.69 M(+32.0%)
Dec 2011
$4.31 M(+6.0%)
$1.28 M(+24.8%)
$4.31 M(+6.9%)
Sep 2011
-
$1.03 M(-48.6%)
$4.04 M(-33.5%)
Jun 2011
-
$2.00 M(+99.1%)
$6.07 M(+49.2%)
Dec 2010
$4.07 M(-8.1%)
$1.00 M(-67.2%)
$4.07 M(+32.8%)
Sep 2010
-
$3.07 M(-403.0%)
$3.07 M(>+9900.0%)
Jun 2010
-
-$1.01 M(-200.0%)
$0.00(-100.0%)
Mar 2010
-
$1.01 M
$1.01 M
Dec 2009
$4.43 M(+15.7%)
-
-
Dec 2008
$3.83 M
-
-

FAQ

  • What is Pacira BioSciences annual depreciation & amortization?
  • What is the all time high annual D&A for Pacira BioSciences?
  • What is Pacira BioSciences annual D&A year-on-year change?
  • What is Pacira BioSciences quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Pacira BioSciences?
  • What is Pacira BioSciences quarterly D&A year-on-year change?
  • What is Pacira BioSciences TTM depreciation & amortization?
  • What is the all time high TTM D&A for Pacira BioSciences?
  • What is Pacira BioSciences TTM D&A year-on-year change?

What is Pacira BioSciences annual depreciation & amortization?

The current annual D&A of PCRX is $75.57 M

What is the all time high annual D&A for Pacira BioSciences?

Pacira BioSciences all-time high annual depreciation & amortization is $91.50 M

What is Pacira BioSciences annual D&A year-on-year change?

Over the past year, PCRX annual depreciation & amortization has changed by -$15.93 M (-17.41%)

What is Pacira BioSciences quarterly depreciation & amortization?

The current quarterly D&A of PCRX is $20.25 M

What is the all time high quarterly D&A for Pacira BioSciences?

Pacira BioSciences all-time high quarterly depreciation & amortization is $30.41 M

What is Pacira BioSciences quarterly D&A year-on-year change?

Over the past year, PCRX quarterly depreciation & amortization has changed by +$1.82 M (+9.87%)

What is Pacira BioSciences TTM depreciation & amortization?

The current TTM D&A of PCRX is $76.03 M

What is the all time high TTM D&A for Pacira BioSciences?

Pacira BioSciences all-time high TTM depreciation & amortization is $91.50 M

What is Pacira BioSciences TTM D&A year-on-year change?

Over the past year, PCRX TTM depreciation & amortization has changed by -$11.47 M (-13.11%)